Month: January 2024

Trust Stamp has filed a provisional patent application (USPTO: 63/611,799) with the US Patent and Trademark Office for its new Stable IT2TM technology that is designed to transform the landscape of biometric identity authentication ATLANTA, Jan. 04, 2024 (GLOBE NEWSWIRE) — Trust Stamp (Nasdaq: IDAI), the Privacy-First Identity CompanyTM, providing AI-powered trust and identity services, has announced the filing of a provisional patent application for its new Stable IT2TM technology. Stable IT2 is a groundbreaking facial recognition technology designed for identity authentication, secure system access, and account protection. It uses a cryptographic token generated from a user’s facial biometrics to respond to cryptographic challenges and authenticate messages, enhancing security and user control over personal information. At registration,...

The information of Vilvi group will be released as follows: 10th day of each month of 2024 – consolidated sales for the last month;February 29, 2024 – Interim Financial Statements for 12 months of 2023; April 5, 2024 – audited financial statements of 2023;April 26, 2024 – Ordinary General Meeting of Shareholders; May 31, 2024 – Interim Financial Statements for 3 months of 2024; August 30, 2024 – Interim Financial Statements for 6 months of 2024; November 29, 2024– Interim Financial Statements for 9 months of 2024. Vilija Milaseviciute Economic and finance director Tel.: +370 441 55 102

Company has delivered a total of 241 Class 1 and Class 3 EVs to RMATo date, Randy Marion Automotive (“RMA”) has been invoiced $12,559,520 for Class 1 and 3 EVs.Company delivered 100 Class 1 and 141 Class 3 vehicles thru Dec. 31, 2023, to Randy Marion Automotive Group; Company has an additional 185 Class 1 vehicles scheduled for delivery through Jan. 8, 2024 Vehicles delivered to Randy Marion are part of the 6,000 Class 1 vehicle purchase order of $200,000,000 and the 1,000 Class 3 vehicle purchase order for $63,000,000; majority of vehicles to be delivered through calendar year 2024BREA, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) — via IBN — Mullen Automotive, Inc. (NASDAQ: MULN) (“Mullen” or the “Company”), an emerging electric vehicle (“EV”) manufacturer, today announces vehicles delivered through Dec....

Dr. Sanchorawala co-authored landmark study of daratumumab (DARZALEX®) in AL Amyloidosis published in The New England Journal of Medicine, 2021 that led to it becoming a first-line standard of care LOS ANGELES, Jan. 04, 2024 (GLOBE NEWSWIRE) — Immix Biopharma, Inc. (“Immix Biopharma”, “Company”, “We” or “Us”, Nasdaq:IMMX), announced that effective today, Vaishali Sanchorawala, MD, has joined ImmixBio subsidiary Nexcella Scientific Advisory Board.  Dr. Sanchorawala is internationally recognized for her pioneering work in development of novel agents to treat AL Amyloidosis, including the establishment of daratumumab as the standard of care. “Therapeutic landscape of AL amyloidosis is evolving. There is a marked progress in survival of patients with AL amyloidosis. However, better and more effective therapies are needed for those...

CELEBRATION, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) — Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra or the Company), a rare disease therapeutics company, today announced the appointment of Adrian Quartel, M.D., FFPM, as Chief Medical Officer. Dr. Quartel brings more than 20 years of experience in the international pharmaceutical industry with senior roles in clinical development, pharmacovigilance and medical affairs. “It is an honor to welcome Dr. Quartel to our team during an exciting period of growth for Zevra after our recent acquisition of Acer Therapeutics and the expansion of our rare disease portfolio,” said Neil F. McFarlane, President and Chief Executive Officer of Zevra. “His extensive expertise in overseeing clinical development and leading the commercialization of multiple rare disease assets will play a pivotal...

Final validation report expected in first quarter 2024 ENGLEWOOD CLIFFS, NJ, Jan. 04, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company”), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today provided an update on its previously announced dose-ranging study of SPC-15, a targeted prophylactic treatment for post-traumatic stress disorder (PTSD). The purpose of the study is to identify the maximum tolerated intranasal dose of the drug and pharmacokinetic in small animals to determine the therapeutically relevant dose range with the goal of bringing us closer to human trials. The six- to eight-week non-GLP study includes single ascending dose evaluation (phase 1) and a 7-day repeat intranasal dose toxicity and pharmacokinetic study....

LeapChargerRedesigned PackagingCARSON CITY, NV, Jan. 04, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – LeapCharger Corporation (OTC: LCCN) (“LeapCharger” or the “Company”), an electric vehicle (EV) charging company with disruptive and innovative technology providing eco-friendly and sustainable solutions, is pleased to announce its foray into the retail sector. The Company intends to revolutionize the industry by making its line of home EV charging solutions available for purchase on the shelves of supermarkets in Dubai. LeapCharger’s recently completed new line of home EV charging solutions is designed to meet the burgeoning demand for accessible and efficient charging options. With a commitment to sustainable mobility, the company aims to empower EV owners by bringing the charging experience directly...

Record Numbers Reported Both in December 2023 and Q4 of 2023 JOHNS CREEK, Ga., Jan. 04, 2024 (GLOBE NEWSWIRE) — Ebix, Inc. (OTC: EBIXQ), a leading international supplier of On-Demand software and E-commerce services to the insurance, financial, healthcare, and e-learning industries, announced today that its Annuity Exchange AN4 has reported record volumes in the last quarter of 2023, besides reporting a record performance for the full year of 2023. Ebix’s AN4 Annuity exchange is an integral key part of Ebix’s North America Life & Annuity Division, that includes other assets like LifeSpeed, the industry leading Order Entry platform; WinFlex, a market-leading multi-carrier illustration tool used by over 35 carriers and more than 275,000 users; TPP (The Policy Processor), an industry leading underwriting platform; and SmartOffice,...